Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.12.09.519852

Expanding the diversity of Accumulibacter with a novel type and deciphering the transcriptional and morphological features among co-occurring strains

Abstract

Accumulibacter is the major polyphosphate-accumulating organism (PAO) in global wastewater treatment systems. Its phylogenetic and functional diversity has been continuously updated in recent years. In addition to its widely recognized two sublineages, Types I and II, here we discovered a novel type enriched in laboratory bioreactors. Core gene- and machine learning-based gene feature profiling supported that Type III Accumulibacter was potential PAO with the unique function of using dimethyl sulfoxide as electron acceptor. On the basis of the correlation between the similarity of ppk1 and genome, the number of ppk1-represented Accumulibacter species was estimated to be over one hundred, suggesting that the currently recognized species are only the tip of the iceberg. Meanwhile, multiple Accumulibacter strains co-occurring in a bioreactor were investigated for their inter-strain transcriptional and morphological features. Metatranscriptomics of seven co-occurring strains indicated that the expression level and interphasic dynamics of PAO phenotype-related genes had minimal correlation with their phylogeny. In particular, expression of denitrifying and poly-P metabolism genes had higher inter-strain and interphasic divergence compared with glycogen and polyhydroxyalkanoates metabolic genes. A strategy of cloning rRNA genes from different strains based on similar genomic synteny was successfully applied to differentiate their morphology via fluorescence in situ hybridization. Our study further expanded the phylogenetic and functional diversity of Accumulibacter. We also proposed that deciphering the function and capability of certain Accumulibacter should be environment- and population-specific. ImportanceAccumulibacter, as the core functional but uncultured taxa for enhanced biological phosphorus removal, has attracted much attentions on its phylogenetic and functional diversity and intra-genus niche differentiation in the last two decades. It was well-known that this genus had two sub-lineages (Type I and II) since 2002. In this study, a novel type (Type III) with proposed novel functional feature was discovered by the metagenomic approach. By linking average nucleotide identity of Accumulibacter genomes and the similarity of the ppk1 sequences, a phylogenetic biomarker that has been largely deposited in database, we estimated that its global species-level diversity was higher than 100. Moreover, as we found the co-occurrence of multiple Accumulibacter strains in one bioreactor, the simultaneous transcriptional divergence of the co-occurring strains was interesting for understanding their niche differentiation in a single community. The results suggested the decoupling feature between transcriptional pattern with phylogeny for co-occurring strains.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wang, Z.-j., Song, W., Zhang, X., Zheng, M., Li, H., Yu, K., Guo, F.. 2022-12-11. Expanding the diversity of Accumulibacter with a novel type and deciphering the transcriptional and morphological features among co-occurring strains. https://doi.org/10.1101/2022.12.09.519852

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗